גאלבוס 50 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

VILDAGLIPTIN 50 MG

Pieejams no:

NOVARTIS PHARMA SERVICES AG

ATĶ kods:

A10BH02

Zāļu forma:

TABLETS

Ievadīšanas:

PER OS

Ražojis:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Ārstniecības grupa:

VILDAGLIPTIN

Ārstēšanas norādes:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

Autorizācija datums:

2008-12-01